- Home
- CRDF vs SWIN Comparison
CRDF vs SWIN Comparison
Compare CRDF & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- SWIN
- Stock Information
- Founded
- CRDF 1999
- SWIN 2017
- Country
- CRDF United States
- SWIN Hong Kong
- Employees
- CRDF N/A
- SWIN N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- SWIN
- Sector
- CRDF Health Care
- SWIN
- Exchange
- CRDF Nasdaq
- SWIN Nasdaq
- Market Cap
- CRDF 233.5M
- SWIN 258.0M
- IPO Year
- CRDF N/A
- SWIN 2023
- Fundamental
- Price
- CRDF $2.32
- SWIN $3.73
- Analyst Decision
- CRDF Strong Buy
- SWIN
- Analyst Count
- CRDF 6
- SWIN 0
- Target Price
- CRDF $10.58
- SWIN N/A
- AVG Volume (30 Days)
- CRDF 2.9M
- SWIN 649.6K
- Earning Date
- CRDF 07-29-2025
- SWIN 06-30-2025
- Dividend Yield
- CRDF N/A
- SWIN N/A
- EPS Growth
- CRDF N/A
- SWIN N/A
- EPS
- CRDF N/A
- SWIN N/A
- Revenue
- CRDF $545,000.00
- SWIN $3,316,000.00
- Revenue This Year
- CRDF N/A
- SWIN $29.79
- Revenue Next Year
- CRDF N/A
- SWIN $54.60
- P/E Ratio
- CRDF N/A
- SWIN N/A
- Revenue Growth
- CRDF N/A
- SWIN N/A
- 52 Week Low
- CRDF $2.09
- SWIN $1.16
- 52 Week High
- CRDF $5.64
- SWIN $5.09
- Technical
- Relative Strength Index (RSI)
- CRDF 34.12
- SWIN 44.35
- Support Level
- CRDF $2.22
- SWIN $4.10
- Resistance Level
- CRDF $2.56
- SWIN $4.68
- Average True Range (ATR)
- CRDF 0.13
- SWIN 0.50
- MACD
- CRDF 0.01
- SWIN -0.09
- Stochastic Oscillator
- CRDF 25.64
- SWIN 8.11
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.